Description
| Product Name | CAT.No | Size |
| Toxoplasmosis Latex | LXTX0100 | 100T |
| Toxoplasmosis Latex | LXT001L | 25,000T |
Product Description
The Biorex Diagnostics Toxoplasmosis Latex Test is a rapid slide agglutination assay designed for the qualitative and semi-quantitative detection of antibodies to Toxoplasma gondii in human serum. Toxoplasmosis is a common parasitic infection that can cause serious clinical complications, particularly in pregnant women, immunocompromised patients, and neonates. Accurate and timely serological testing is therefore essential for diagnosis, screening, and ongoing monitoring of infection. This test provides a simple, reliable, and cost-effective solution for routine use in clinical laboratories, hospitals, and diagnostic centres.
The assay utilises latex particles coated with Toxoplasma gondii antigen, which react with specific antibodies present in patient serum to produce visible agglutination. The slide-based method allows for rapid result interpretation without the need for specialised instrumentation, making it suitable for both high-throughput laboratories and facilities with limited resources. Its ability to deliver qualitative screening results as well as semi-quantitative antibody titres supports both initial diagnosis and follow-up testing.
Key Features
- Rapid slide agglutination method – delivers fast and easily interpretable results
- Qualitative and semi-quantitative testing – supports screening and antibody titre estimation
- High sensitivity and specificity – reliable detection of anti-Toxoplasma gondii antibodies
- Minimal equipment required – ideal for laboratories with limited infrastructure
- Ready-to-use reagents – simplifies testing procedures and reduces preparation errors
Benefits
The Biorex Diagnostics Toxoplasmosis Latex Test enables laboratories to perform dependable serological testing with minimal technical complexity. Its rapid methodology supports timely clinical decision-making, which is particularly important for antenatal screening and the management of high-risk patients. The semi-quantitative capability allows laboratories to monitor antibody levels over time, assisting clinicians in assessing disease progression or response to treatment.
The ready-to-use format improves laboratory efficiency by reducing hands-on time and minimising the risk of handling errors, while the requirement for minimal equipment makes the test highly accessible and cost-effective. Consistent performance and clear agglutination patterns support confident result interpretation, even in routine screening environments. By providing a reliable and efficient approach to toxoplasmosis antibody detection, the Biorex Diagnostics Toxoplasmosis Latex Test supports accurate diagnosis, optimised laboratory workflow, and improved patient care across a wide range of clinical settings.
Contact Us for more information.